Jazz Pharmaceuticals Files Patent Infringement Against Generic Drugmakers In New Jersey's District Court
Jazz Pharmaceuticals Announces Q3 2022 Financial Results, Raises Total Revenue Guidance
Celator Surges 70% After Acquisition Announcement By Jazz Pharmaceuticals
How Much Further Can Jazz Pharmaceuticals Fall?
Jazz Pharmaceuticals Recent News
Dow Flirts With 19,000, S&P 500 Approaches 2,000 & NASDAQ Trading At 14-Year Highs
Market Wrap For April 17: Mixed Earnings Drag The Dow Lower While S&P 500 & Nasdaq End Positive
Market Wrap For March 31: Stocks Rally As Yellen Confirms Support For Economy
Market Wrap For March 28: Markets Still Positive Despite Giving Up Early Gains
Market Wrap For March 7: Markets Cap Off Positive Week With Small Gains
Market Wrap For December 20: Markets Gain On GDP Data
Market Wrap For December 16: Dow Posts Triple Point Gain Ahead of Fed Meeting
Earnings Expectations For The Week Of November 4: Disney, Tesla, Groupon And More
Best Biotech Stocks of 2011
Piper Jaffray: Jazz Pharmaceuticals Not Expecting Payer Pushback In Wake Of Price Hike